Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?-Reference-Cited by-同舟云学术

Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?

Published:2023-11-19 Issue: Volume: Page:
ISSN:1573-2584
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Beijert Irene J.^ORCID,Hentschel Anouk E.,Bründl Johannes,Compérat Eva M.,Plass Karin,Rodríguez Oscar,Subiela Henríquez Jose D.,Hernández Virginia,de la Peña Enrique,Alemany Isabel,Turturica Diana,Pisano Francesca,Soria Francesco,Čapoun Otakar,Bauerová Lenka,Pešl Michael,Bruins H. Maxim,Runneboom Willemien,Herdegen Sonja,Breyer Johannes,Brisuda Antonin,Calatrava Ana,Rubio-Briones José,Seles Maximilian,Mannweiler Sebastian,Bosschieter Judith,Kusuma Venkata R. M.,Ashabere David,Huebner Nicolai,Cotte Juliette,Contieri Roberto,Mertens Laura S.,Claps Francesco,Masson-Lecomte Alexandra,Liedberg Fredrik,Cohen Daniel,Lunelli Luca,Cussenot Olivier,El Sheikh Soha,Volanis Dimitrios,Côté Jean-François,Rouprêt Morgan,Haitel Andrea,Shariat Shahrokh F.,Mostafid A. Hugh,Nieuwenhuijzen Jakko A.,Zigeuner Richard,Dominguez-Escrig Jose L.,Hacek Jaromir,Zlotta Alexandre R.,Burger Maximilian,Evert Matthias,Hulsbergen-van de Kaa Christina A.,van der Heijden Antoine G.,Kiemeney Lambertus A. L. M.,Soukup Viktor,Molinaro Luca,Gontero Paolo,Llorente Carlos,Algaba Ferran,Palou Joan,N’Dow James,Ribal Maria J.,van der Kwast Theo H.,Babjuk Marko,Sylvester Richard J.,van Rhijn Bas W. G.

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s11255-023-03867-9.pdf

Reference16 articles.

1. Babjuk M, Burger M, Capoun O et al (2022) European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ). Eur Urol 81(1):75–94. https://doi.org/10.1016/j.eururo.2021.08.010[publishedOnlineFirst:2021/09/14]

2. Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F (2010) Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 58(2):185–190. https://doi.org/10.1016/j.eururo.2010.03.007[publishedOnlineFirst:2010/03/23]

3. Naselli A, Hurle R, Paparella S et al (2018) Role of restaging transurethral resection for T1 non-muscle invasive bladder cancer: a systematic review and meta-analysis. Eur Urol Focus 4(4):558–567. https://doi.org/10.1016/j.euf.2016.12.011[publishedOnlineFirst:2017/07/30]

4. Eroglu A, Ekin RG, Koc G, Divrik RT (2020) The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial. Int J Clin Oncol 25(4):698–704. https://doi.org/10.1007/s10147-019-01581-0[publishedOnlineFirst:2019/11/25]

5. Grimm MO, Steinhoff C, Simon X, Spiegelhalder P, Ackermann R, Vogeli TA (2003) Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 170(2 Pt 1):433–437. https://doi.org/10.1097/01.ju.0000070437.14275.e0